(Q48699422)

English

Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level

scientific article published on 2 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

adaptive radiation therapy

0 references

differentiated thyroid carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Heribert Hänscheid

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

Frederik Anton Verburg

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

Johannes Biko

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

Stefanie Diessl

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

Yuri E Demidchik

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

Valentina Drozd

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

Christoph Reiners

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

publication date

2 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

38

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

1296-1302

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1788-Y

21 January 2018

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1788-Y

21 January 2018

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1788-Y

21 January 2018

No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1788-Y

21 January 2018

Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1788-Y

21 January 2018

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1788-Y

21 January 2018

Estimation and prediction of blood volume in infants and children

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1788-Y

21 January 2018

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/21461735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21461735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21461735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21461735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21461735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21461735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thyroid cancer in infants and adolescents after Chernobyl.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21461735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21461735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-011-1788-Y

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21461735

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48699422&oldid=2209710317"